Fly News Breaks for March 9, 2015
TRNX
Mar 9, 2015 | 11:38 EDT
Wells Fargo indicated that Tornier's Simpliciti ultra-short stem total shoulder was cleared by FDA well ahead of the company's mid-2015 guidance, noting that the company has previously said it thinks shoulders such as the Simpliciti have a market opportunity of $200M-$250M. Wells has a Market Perform rating on Tornier shares.
News For TRNX From the Last 2 Days
There are no results for your query TRNX